echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Radio wave devices can remotely track Parkinson's disease and treatment responses at home| Science and Translational Medicine

    Radio wave devices can remotely track Parkinson's disease and treatment responses at home| Science and Translational Medicine

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Click on the blue word above and follow us



    According to a year-long study involving 50 participants, scientists have created a new device that captures radio waves in patients' homes, which tracks
    the progression of Parkinson's disease and the effects of medications.

    Because patients are challenged to travel to clinical centers for traditional examinations and testing, the device can meet the growing need to
    evaluate Parkinson's disease methods at home.


    Parkinson's disease can cause debilitating motor symptoms and tremors, which can interfere with the patient's gait and ability to walk; Developing new treatments requires tests that can objectively track disease progression and drug utility
    .

    However, patients may have difficulty traveling to city centers where most disease specialists are located, so many patients end up not being able to see a neurologist
    .
    To meet the need for home testing, Yingcheng Liu and colleagues invented a device that eliminates the need
    for patients to wear sensors or actively self-test.

    Their device is similar to a WiFi router that can be placed in a home, and it can stably detect radio waves
    reflected from a person's body.
    Based on these radio waves, the device can infer the patient's gait speed and any interruptions they experience while exercising, allowing for continuous monitoring
    of the patient's motor symptoms.

    The team tested the device for a year in the homes of 34 Parkinson's patients and 16 healthy subjects, collecting 200,000 gait test values associated with the gold standard for disease ratings
    .

    In addition, the device also acquired the way
    gait measurements fluctuated throughout the day in response to taking drugs such as levodopa.
    Liu et al.
    said the findings are "significant, especially given the social distancing measures required as a result of the COVID-19 pandemic and the growing
    number of people with chronic diseases.
    "
    Welcome
    to pay attention to the official public account of Science and click "Read the original article" to access the original English text to light up your "like" for medical research
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.